Fida Biosystems

Fida Biosystems develops the Fida Evolve platform, a biophysical analysis instrument that utilizes Flow Induced Dispersion Analysis (FIDA) to characterize molecular binding and sample integrity. The technology measures over ten parameters, including hydrodynamic radius, binding affinity (pM to mM), and kinetics, directly in complex samples like cell lysates and plasma without requiring purification. The company serves researchers in academia, contract research organizations (CROs), and drug discovery sectors focusing on modalities such as lipid nanoparticles, CRISPR, and engineered antibodies.